Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Coronary Disease and CYP2C19[original query] |
---|
Diversity of platelet function and genetic polymorphism in clopidogrel-treated Chinese patients. Genetics and molecular research : GMR 2015 14 (1): 1434-42. Sun B, Li J, Dong M, Yang L, Wu C, Zhu L, Cong Y |
CYP2C19 activity and cardiovascular risk factors in patients with an acute coronary syndrome. Medicina clinica 2017 May . Martínez-Quintana Efrén, Rodríguez-González Fayna, Medina-Gil José María, Garay-Sánchez Paloma, Tugores Anton |
Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients: An observational study. Medicine 2020 Apr 99 (15): e19472. Fu Hefei, Hu Pan, Ma Chunmei, Peng Fei, He Zhi |
The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A), *3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology 2021 Jun 17 (2): 179-186. Wójcik Tomasz, Karolko Bo?ena, Wi?niewski Jerzy, Mysiak Andrzej, ?ciborski Krzysztof, Onisk Grzegorz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marc |
Clinical and Pharmacological Parameters Determine Relapse During Clopidogrel Treatment of Acute Coronary Syndrome. Journal of clinical pharmacology 2021 12 62 (6): 783-791. Santana-Mateos Marta, Medina-Gil José M, Saavedra-Santana Pedro, Martínez-Quintana Efrén, Rodríguez-González Fayna, Tugores Anton |
CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel. Clinical and translational science 2023 8 . Markus Ramste, Markus Ritvos, Sergei Häyrynen, Johanna I Kiiski, Mikko Niemi, Juha Sinisa |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 28, 2024
- Content source: